Survivorship: Psychosocial, Physical Issues, and Insomnia

  • Melissa Y. Carpentier
  • Tammy Weitzmann
  • Ziv Amir
  • Grace E. Dean
  • Ian N. Olver


Surviving cancer is associated with both psychosocial and physical sequelae, which must be recognized and preempted or treated. Most adult cancer survivors do not have evidence of significant symptoms of depression, anxiety, and/or posttraumatic stress, but some symptoms exist for many survivors although there is great variation in reporting. Pediatric cancer survivors have a more standardized approach toward assessing psychosocial sequelae of survivors and more long-term psychosocial and physical problems are found.

Adjustment disorder is a stress-related, short-term, nonpsychotic condition where patients have intense reactions to situations or events. A model of continuity of long-term psychosocial care is needed. Social coping after the diagnosis and treatment of cancer should be assessed as patients and their families may benefit from information about support from health and social care experts. Long-term physical problems may include residual effects of the cancer or its treatment by surgery radiation or chemotherapy. There can be long-term organ toxicities including cardiac, pulmonary, neurological, renal hepatic, and endocrine including infertility or general symptoms such as fatigue and insomnia. Second cancers triggered by the therapy can be late effects of treatment.


Cancer Survivor Testicular Cancer Total Sleep Time Cytosine Arabinoside Sleep Diary 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105.PubMedCrossRefGoogle Scholar
  2. 2.
    Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:32–39.PubMedCrossRefGoogle Scholar
  3. 3.
    Pirl WF, Greer J, Temel JS, et al. Major depressive disorder in long-term cancer survivors: Analysis of the National Comorbidity Survey Replication. J Clin Oncol. 2009;27:4130–4134.PubMedCrossRefGoogle Scholar
  4. 4.
    Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. J Clin Oncol. 2004;22:4829–4836.PubMedCrossRefGoogle Scholar
  5. 5.
    Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol. 2002;97:1228–1234.PubMedCrossRefGoogle Scholar
  6. 6.
    Dahl AA., Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:2389–2395.PubMedCrossRefGoogle Scholar
  7. 7.
    Ganz PA, Rowland JH, Meyerowitz BE, Desmond KA. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res. 1998;152:396–411.PubMedCrossRefGoogle Scholar
  8. 8.
    Keating NL, Norredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc. 2005;53:2145–2152.PubMedCrossRefGoogle Scholar
  9. 9.
    Andersen BL, Tewfik HH. Psychological reactions to radiation therapy: Reconsideration of the adaptive aspects of anxiety. J Pers Soc Psychol. 1985;48:1024–1032.PubMedCrossRefGoogle Scholar
  10. 10.
    Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20;3137–3148.PubMedCrossRefGoogle Scholar
  11. 11.
    van’t Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980. Psychosom Med. 1997;59:280–293.PubMedGoogle Scholar
  12. 12.
    Stark DPH, House A. Anxiety in cancer patients. Br J Cancer. 2000;83:1261–1267.PubMedCrossRefGoogle Scholar
  13. 13.
    Ashbury FD, Findlay H, Reynolds B, McKerracher K. A Canadian survey of cancer patients’ experiences: Are their needs being met? J Pain Symptom Manage. 1998;16:298–306.PubMedCrossRefGoogle Scholar
  14. 14.
    Noyes RJ, Holt C, Massie M. Anxiety disorders. In: Holland JC ed. Psycho-oncology. New York: Oxford; 1998:548–563.Google Scholar
  15. 15.
    Andrykowski MA, Lykins E, Floyd A. Psychological health in cancer survivors. Semin Oncol Nurs. 2008;24:193–201.PubMedCrossRefGoogle Scholar
  16. 16.
    Mundy EA, Blanchard EB, Cirenza E, et al. Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behav Res Ther. 2000;38:1015–1027.PubMedCrossRefGoogle Scholar
  17. 17.
    Naidich JB, Motta RW. PTSD-related symptoms in women with breast cancer. J Psychother Independ Pract. 2000;1:35–54.CrossRefGoogle Scholar
  18. 18.
    Andrykowski MA, Cordova MJ. Factors associated with PTSD symptoms following treatment for breast cancer: Test of the Andersen model. J Trauma Stress. 1998;11:189–203.PubMedCrossRefGoogle Scholar
  19. 19.
    Andrykowski MA, Cordova MJ, Studts JL, Miller TW. Posttraumatic stress disorder after treatment for breast cancer: Prevalence of diagnosis and use of the PTSD Checklist – Civilian Version (PCL-C) as a screening instrument. J Consult Clin Psychol. 1998;66:586–590.PubMedCrossRefGoogle Scholar
  20. 20.
    Cordova MJ, Andrykowski MA, Redd WH, et al. Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J Consult Clin Psychol. 1995;63: 981–986.PubMedCrossRefGoogle Scholar
  21. 21.
    Smith MY, Redd W, DuHamel K, Vickberg SJ, Ricketts P. Validation of the PTSD – Civilian version in survivors of bone marrow transplantation. J Trauma Stress. 1999;12:485–499.PubMedCrossRefGoogle Scholar
  22. 22.
    Jacobsen PB, Widows MR, Hann DM, Andrykowski MA, Kronish LE, Fields KK. Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med. 1998; 60:366–371.PubMedGoogle Scholar
  23. 23.
    Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer: A conceptual and empirical review. Clin Psychol Rev. 2002;22:499–524.PubMedCrossRefGoogle Scholar
  24. 24.
    Green BL, Rowland JH, Krupnick JL, et al. Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics. 1998;39:102–111.PubMedCrossRefGoogle Scholar
  25. 25.
    Jim HSL, Jacobsen PB. Posttraumatic stress and posttraumatic growth in cancer survivorship: A review. Cancer J. 2008;14: 414–419.PubMedCrossRefGoogle Scholar
  26. 26.
    Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2396–2404.PubMedCrossRefGoogle Scholar
  27. 27.
    Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: A report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2008;17:435–446.PubMedCrossRefGoogle Scholar
  28. 28.
    Mulrooney DA, Ness KK, Neglia JP, et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Sleep. 2008;31:271–281.PubMedGoogle Scholar
  29. 29.
    Zebrack BJ, Gurney JG, Oeffinger K, et al. Psychological outcomes in long-term survivors of childhood brain cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2004;22:999–1006.PubMedCrossRefGoogle Scholar
  30. 30.
    Benton TD, Ifeagwu JA. Adjustment disorders. eMedicine Psychiatry. 2009:1–9.Google Scholar
  31. 31.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.CrossRefGoogle Scholar
  32. 32.
    Snyder S, Strain JJ, Wolf D. Differentiating major depression from adjustment disorder with depressed mood in the medical setting. Gen Hosp Psychiatry. 1990;12:159–165.PubMedCrossRefGoogle Scholar
  33. 33.
    Fobair P, Hoppe RT, Bloom J, et al. Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol. 1986;4: 805–814.PubMedGoogle Scholar
  34. 34.
    Weddington WW, Segraves BK, Simon MA. Current and lifetime incidence of psychiatric disorders among a group of extremity sarcoma survivors. J Psychosom Med. 1986;30:121–125.CrossRefGoogle Scholar
  35. 35.
    Grassi L, Rosti G. Psychosocial morbidity and adjustment to illness among long term cancer survivors. Psychosomatics. 1996;37:523–532.PubMedCrossRefGoogle Scholar
  36. 36.
    Guex P, Stiefel F, Rouselle I. Psychotherapy with patients with cancer. Psychother Rev. 2000;2:269–273.Google Scholar
  37. 37.
    Lewis FM. The effects of cancer survivorship on families and caregivers. Cancer Nurs. 2006;29:20–25.PubMedCrossRefGoogle Scholar
  38. 38.
    Kitrungrote L, Cohen MZ. Quality of life of family caregivers of patients with cancer: A literature review. Oncol Nurs Forum. 2006;33:625–632.CrossRefGoogle Scholar
  39. 39.
    van Tulder MW, Aaronson NK, Burning PF. The quality of life of long-term survivors of Hodgkin’s disease. Ann Oncol. 1994;5: 153–158.PubMedGoogle Scholar
  40. 40.
    Hallas CN, Patel N, Oo A, et al. Five-year survival following oesophageal cancer resection: Psychosocial functioning and quality of life. Psychol Health Med. 2001;6:85–94.Google Scholar
  41. 41.
    Wenzel LB, Donnelly JP, Fowler JM, et al. Resilience, reflection and residual stress in ovarian cancer survivorship: A gynaecologic oncology group study. Psychooncology. 2002;11:142–153.PubMedCrossRefGoogle Scholar
  42. 42.
    Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA. Long term medical outcomes and quality of life assessment of patients with chronic myloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol. 2002;1:2334–2343.CrossRefGoogle Scholar
  43. 43.
    Halstead MT, Fernsler JI. Coping strategies of long-term cancer survivors. Cancer Nurs. 1994;17:94–100.PubMedCrossRefGoogle Scholar
  44. 44.
    Joly F, Heron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: A population-based control study. J Clin Oncol. 2002;20:73–80.PubMedCrossRefGoogle Scholar
  45. 45.
    Bloom JR, Stewart SL, Chang S, Banks PJ. Then and now: Quality of life of young breast cancer survivors. Psychooncology. 2004;13:147–160.PubMedCrossRefGoogle Scholar
  46. 46.
    Wyatt G, Kurtz ME, Linken M. Breast cancer survivors: An exploration of quality of life issues. Cancer Nurs. 1993;16:440–448.PubMedCrossRefGoogle Scholar
  47. 47.
    Amir M, Ramati A. Post traumatic symptoms, emotional distress and quality of life in long-term survivors of breast cancer: A preliminary research. J Anxiety Disord. 2002;16:195–206.PubMedGoogle Scholar
  48. 48.
    Matthews AK, Aikens JE, Helmrich SP, Anderson DD, Herbst AL, Waggoner SE. Sexual functioning and mood among long-term survivors of clear-cell adenocarcinoma of the vagina or cervix. J Psychosoc Oncol. 1999;17:27–45.CrossRefGoogle Scholar
  49. 49.
    Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med. 1995;40:479–490.PubMedCrossRefGoogle Scholar
  50. 50.
    Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat. 2002;75: 241–248.PubMedCrossRefGoogle Scholar
  51. 51.
    Peteet J. Cancer and the meaning of work. Gen Hosp Psychiatry. 2000;22:200–205.PubMedCrossRefGoogle Scholar
  52. 52.
    de Boer AGEM, Taskila T, Ojajarvi A, et al. Cancer survivors and unemployment: A meta-analysis and meta-regression. JAMA. 2009;301:753–762.PubMedCrossRefGoogle Scholar
  53. 53.
    Amir Z, Neary D, Luker K. Cancer survivors’ views of work 3 years post diagnosis: A UK perspective. Eur J Oncol Nurs. 2008;12:190–197.PubMedCrossRefGoogle Scholar
  54. 54.
    Bednarek HL, Bradley CJ. Work and retirement after cancer diagnosis. Res Nurs Health. 2005;28:126–135.PubMedCrossRefGoogle Scholar
  55. 55.
    Drolet M, Maunsell E, Brisson J, Brisson C, Masse B, Deschenes L. Not working 3 years after breast cancer: Predictors in a population based study. J Clin Oncol. 2005;23:8305–8312.PubMedCrossRefGoogle Scholar
  56. 56.
    Amir Z, Moran T, Walsh L, Iddenden R, Luker K. Return to paid work after cancer: A British experience. J Cancer Surviv. 2007;1: 129–136.PubMedCrossRefGoogle Scholar
  57. 57.
    Lauzier S, Maunsell E, Drolet M, et al. Wage losses in the year after breast cancer: Extent and determinants among Canadian women. J Natl Cancer Inst. 2008;100:321–333.PubMedCrossRefGoogle Scholar
  58. 58.
    Heath JA, Lintuuran M, Rigguto G, Tikotlian N, McCarthy M. Childhood cancer: Its impact and financial costs for Australian families. Pediatr Hematol Oncol. 2006;23:439–448.PubMedCrossRefGoogle Scholar
  59. 59.
    Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with treatment in Ontario, Canada. Support Care Cancer. 2006;14:1077–1185.PubMedCrossRefGoogle Scholar
  60. 60.
    Bradley S, Sherwood PR, Donovan HS, et al. I could lose everything: Understanding the cost of a brain tumour. J Neurooncol. 2007;85:329–338.PubMedCrossRefGoogle Scholar
  61. 61.
    Cohn RJ, Goodenough B, Foreman T, Suneson J. Hidden financial costs in treatment for childhood cancer: An Australian study of life-style implications for families absorbing out-of-pocket expenses. J Pediatr Haematol Oncol. 2003;25:854–863.CrossRefGoogle Scholar
  62. 62.
    Eakin EG, Strycker LA. Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: Patient and provider perspective. Psychooncology. 2001;10:103–113.PubMedCrossRefGoogle Scholar
  63. 63.
    Alter CL. Predictors of referrals for psychosocial services: Recommendations from the Institute of Medicine Report – cancer care for the whole patient. J Clin Oncol. 2009;27:659–660.PubMedCrossRefGoogle Scholar
  64. 64.
    Oeffinger K, Mertens A, Sklar C, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355: 1572–1582.PubMedCrossRefGoogle Scholar
  65. 65.
    Demark-Wahnefried W, Aziz N, Rowland J, et al. Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23:5814–5830.PubMedCrossRefGoogle Scholar
  66. 66.
    van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18: 487–497.PubMedGoogle Scholar
  67. 67.
    Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol. 1999;17(2):569–577.PubMedGoogle Scholar
  68. 68.
    Oeffinger KC, Bhatia S. Second primary cancers in survivors of childhood cancer. Lancet. 2009;374:1484–1485.PubMedCrossRefGoogle Scholar
  69. 69.
    Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2004;4:529–536.CrossRefGoogle Scholar
  70. 70.
    Jones RL, Swanton C, Ewer MS. Anthracycline cardiotoxicity. Expert Opin Drug Saf. 2006;5:791–809.PubMedCrossRefGoogle Scholar
  71. 71.
    Correa CR, Litt HI, Hwang WT, Ferrari VA, Solin LJ, Harris EE. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25:3031–3037.PubMedCrossRefGoogle Scholar
  72. 72.
    Vahid B, Mrik PE. Pulmonary complications of novel antineoplastic agents for solid tumours. Chest. 2008;133:528–538.PubMedCrossRefGoogle Scholar
  73. 73.
    Umapathi T, Chaudhry V. Toxic neuropathy. Curr Opin Neurol. 2005;18:574–580.PubMedCrossRefGoogle Scholar
  74. 74.
    Jaeckle KA. Neurological manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol. 2004;24:385–393.Google Scholar
  75. 75.
    Erbetta A, Salmaggi A, Sghirlanzoni A, et al. Clinical and radiological features of brain neurotoxicity caused by antitumour and immunosuppressant treatments. Neurol Sci. 2008;29:131–137.PubMedCrossRefGoogle Scholar
  76. 76.
    Launay-Vacher V, Rey JB, Isnard-BaGNIS c, Deray G, Daouphars M, European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Prevention of cisplatin nephrotoxicity: State of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol. 2008;61:903–909. Epub 2008 Mar 4.PubMedCrossRefGoogle Scholar
  77. 77.
    Diel IJ, Bergner R, Grötz KA. Adverse effects of bisphosphonates: Current issues. J Support Oncol. 2007;5:475–482.PubMedGoogle Scholar
  78. 78.
    Cleary JM, Tanabe KT, Lauwers GY, Zhu AX. Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. Oncologist. 2009;14:1095–1105. Epub 2009 Oct 30.PubMedCrossRefGoogle Scholar
  79. 79.
    Sateia MJ, Lang BJ. Sleep and cancer: Recent developments. Curr Oncol Rep. 2008;10:309–318.PubMedCrossRefGoogle Scholar
  80. 80.
    Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center–Community Clinical Oncology Program. J Clin Oncol. 2010;28(2):292–298.PubMedCrossRefGoogle Scholar
  81. 81.
    Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59(2):131–136.PubMedCrossRefGoogle Scholar
  82. 82.
    Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29(3):657–661.PubMedCrossRefGoogle Scholar
  83. 83.
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384.PubMedCrossRefGoogle Scholar
  84. 84.
    Reid KJ, Martinovich Z, Finkel S, et al. Sleep: a marker of physical and mental health in the elderly. Am J Geriatr Psychiatry. 2006;14(10):860–866.PubMedCrossRefGoogle Scholar
  85. 85.
    Carter PA. Family caregivers’ sleep loss and depression over time. Cancer Nurs. 2003;26(4):253–259.PubMedCrossRefGoogle Scholar
  86. 86.
    Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005;25(1):117–129.PubMedCrossRefGoogle Scholar
  87. 87.
    Harrison Y, Horne JA. The impact of sleep deprivation on decision making: a review. J Exp Psychol Appl. 2000;6(3):236–249.PubMedCrossRefGoogle Scholar
  88. 88.
    Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: Dose–response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26(2): 117–126.PubMedGoogle Scholar
  89. 89.
    Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol. 2005;3:349–359.PubMedGoogle Scholar
  90. 90.
    Berger AM, Mitchell SA. Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw. 2008;6:3–13.PubMedGoogle Scholar
  91. 91.
    Wielgus KK, Berger AM, Hertzog M. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncol Nurs Forum. 2009;36: 38–48.PubMedCrossRefGoogle Scholar
  92. 92.
    Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer. 2006;106: 751–758.PubMedCrossRefGoogle Scholar
  93. 93.
    O’Donnell JF. Insomnia in cancer patients. Clin Cornerstone. 2004;6 Suppl:S6–S14.PubMedCrossRefGoogle Scholar
  94. 94.
    Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale J, Cohen-Zion M, Fiorentino L. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14:201–209.PubMedCrossRefGoogle Scholar
  95. 95.
    Byar KL, Berger AM, Bakken SL, Cetak MA.Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 2006;33:E18–E26.PubMedCrossRefGoogle Scholar
  96. 96.
    Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol. 1993;11:997–1004.PubMedGoogle Scholar
  97. 97.
    Dorrian J, Lamond N, Holmes AL, et al. The ability to self-monitor performance during a week of simulated night shifts. Sleep. 2003;26:871–877.PubMedGoogle Scholar
  98. 98.
    Tishelman C, Degner LF, Rudman A, et al. Symptoms in patients with lung carcinoma: Distinguishing distress from intensity. Cancer. 2005;104:2013–2021.PubMedCrossRefGoogle Scholar
  99. 99.
    Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health Nations Health. 1964;54:11–23.PubMedCrossRefGoogle Scholar
  100. 100.
    Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007;11(3): 163–178.PubMedCrossRefGoogle Scholar
  101. 101.
    Kozachik SL, Bandeen-Roche K. Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs. 2008;31:334–344.PubMedCrossRefGoogle Scholar
  102. 102.
    Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry. 1979;36(1):103–116.PubMedCrossRefGoogle Scholar
  103. 103.
    Taheri S. Sleep and metabolism: Bringing pieces of the jigsaw together. Sleep Med Rev. 2007;11(3):159–162.PubMedCrossRefGoogle Scholar
  104. 104.
    Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009;27:5233–5239.PubMedCrossRefGoogle Scholar
  105. 105.
    Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt). 2007;16:1348–1361.CrossRefGoogle Scholar
  106. 106.
    Parker KP, Bliwise DL, Ribeiro M, et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol. 2008;26:2464–2472.PubMedCrossRefGoogle Scholar
  107. 107.
    Otte JL, Carpenter JS. Theories, models, and frameworks related to sleep–wake disturbances in the context of cancer. Cancer Nurs. 2009;32:90–104.PubMedCrossRefGoogle Scholar
  108. 108.
    Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10: 541–553.PubMedGoogle Scholar
  109. 109.
    Berger AM. Update on the state of the science: Sleep–wake disturbance in adult patients with cancer. Oncol Nurs Forum. 2009;36: E165–E177.PubMedCrossRefGoogle Scholar
  110. 110.
    Edinger J, et al. Derivation of research diagnostic criteria for insomnia: Report of an American Academy of Sleep Medicine Work Group. Sleep. 2004;27:1567–1596.PubMedGoogle Scholar
  111. 111.
    National Institutes of Health. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13–15, 2005. Sleep. 2005;28:1049–1057.Google Scholar
  112. 112.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J. An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia. Sleep Med. 2006;7:17–24.PubMedCrossRefGoogle Scholar
  113. 113.
    Holbrook A, Crowther R, Lotter A, Endeshaw Y. The role of benzodiazepines in the treatment of insomnia: Meta-analysis of benzodiazepine use in the treatment of insomnia. J Am Geriatr Soc. 2001;49:824–826.PubMedCrossRefGoogle Scholar
  114. 114.
    IMS Health. National prescription audit. 2003.Google Scholar
  115. 115.
    Culpepper L. Secondary insomnia in the primary care setting: Review of diagnosis, treatment, and management. Curr Med Res Opin. 2006;22:1257–1268.PubMedCrossRefGoogle Scholar
  116. 116.
    Smith MT, Perlis, ML, Park, A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159:5–11.PubMedCrossRefGoogle Scholar
  117. 117.
    Arnedt JT, Conroy D, Brower KJ. Treatment options for sleep disturbances during alcohol recovery. J Addict Dis. 2007;26: 41–54.PubMedCrossRefGoogle Scholar
  118. 118.
    American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual, Second edition. Westchester, IL: Author; 2005.Google Scholar
  119. 119.
    Fetveit A. Late-life insomnia: A review. Geriatr Gerontol Int. 2009;9:220–234.PubMedCrossRefGoogle Scholar

Copyright information

© Society for Imaging Informatics in Medicine 2010

Authors and Affiliations

  • Melissa Y. Carpentier
    • 1
  • Tammy Weitzmann
  • Ziv Amir
  • Grace E. Dean
  • Ian N. Olver
  1. 1.Department of Oral Medicine PediatricsIndiana University School of MedicineIndianapolisUSA

Personalised recommendations